Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$12.78 - $23.74 $694,056 - $1.29 Million
-54,308 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$11.73 - $16.08 $47,131 - $64,609
-4,018 Reduced 6.89%
54,308 $716,000
Q2 2021

Aug 11, 2021

BUY
$12.85 - $16.2 $749,489 - $944,881
58,326 New
58,326 $904,000
Q2 2020

Aug 05, 2020

SELL
$11.79 - $15.97 $783,917 - $1.06 Million
-66,490 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$9.31 - $21.24 $619,021 - $1.41 Million
66,490 New
66,490 $894,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.